SAM
LGND icon

Smartleaf Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Smartleaf Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1K Hold
115
– – ﹤0.01% 1686
2026
Q1 		$22.2K Sell
115
-190
-62% -$37.6K ﹤0.01% 1896
2025
Q4 		$58K Buy
305
+34
+13% +$6.53K ﹤0.01% 1475
2025
Q3 		$46.9K Buy
271
+65
+32% +$9.66K ﹤0.01% 1435
2025
Q2 		$23.5K Sell
206
-113
-35% -$12.1K ﹤0.01% 1483
2025
Q1 		$34.3K Sell
319
-87
-21% -$9.84K ﹤0.01% 1342
2024
Q4 		$42.9K Buy
406
+221
+119% +$25K ﹤0.01% 1243
2024
Q3 		$18K Sell
185
-12
-6% -$1.21K ﹤0.01% 1401
2024
Q2 		$16.2K Buy
+197
New +$15.7K ﹤0.01% 1135

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's LGND Position: Q2 2026 in Review

Smartleaf Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 115 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Smartleaf Asset Management first reported a position in LGND in Q2 2024 and has held it in 9 quarters since. The position peaked at $58K in Q4 2025. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Smartleaf Asset Management held 115 shares of Ligand Pharmaceuticals worth $36.1K as of Q2 2026.
  • Smartleaf Asset Management left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1686 holding.
  • Smartleaf Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Ligand Pharmaceuticals position peaked at $58K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.